Alternative Data: Your One True Source
Eagle Alpha is the leading alternative data aggregation platform and advisor. Data VendorData BuyerWhat We Do: Facilitate alpha generation with alternative data
We facilitate the overall functioning of the global alternative data market via our platform and workflow tools. Since its inception, more than 1,000 data buyers have interacted with our platform. We help them understand a vast and growing marketplace of over 1,850 alternative data products. Leading funds, private equity firms, consultants, corporates, and vendors trust Eagle Alpha as their key alternative data solution provider.
Alternative Data Events and Key Content
Alternative Data for Healthcare
This white paper explores the impact of alternative data sources on the healthcare industry, emphasizing their role in enhancing investment decisions in healthcare startups, therapies, and market trends. It delves into patient-generated data, wearables, mobile health apps, social media discussions, and electronic health records (EHRs) as key non-traditional data sources. The report segments healthcare data into four primary categories: R&D and clinical trials, claims data, medical devices data, and other relevant datasets, underscoring the transformative role of AI in healthcare processes. The paper includes sections on investment trends in pharma and biomed, data availability and its applications, the evolution of the pharma industry through AI, real-world case studies demonstrating successful data utilization, and compliance considerations for investors. This summary offers a glimpse into the comprehensive insights provided in the full report by Eagle Alpha, which further includes additional case studies and details on alternative data providers not covered here. For more detailed information and access to a broad catalog of data products, the report encourages contacting Eagle Alpha directly.
Nowcasting as a Driver for Alternative Data Adoption
Nowcasting, as discussed in our alternative data blog, uses real-time data to estimate current conditions, aiding swift decision-making and contrasting with delayed economic indicators.
Corporate Data Monetization: The Opportunity is Now
This alternative data report summarizes webinar presentations of five leading organizations in the corporate data monetization ecosystem – EY, West Monroe, Gulp Data, Cerberus, iHerb, and Schulte Roth + Zabel.
Eagle Alpha’s 3rd Annual Alternative Data Report 2023
This annual alternative data report includes granular industry trends, data sourcing, leading case studies, and technical product updates.
Alternative Data for Healthcare
This white paper explores the impact of alternative data sources on the healthcare industry, emphasizing their role in enhancing investment decisions in healthcare startups, therapies, and market trends. It delves into patient-generated data, wearables, mobile health apps, social media discussions, and electronic health records (EHRs) as key non-traditional data sources. The report segments healthcare data into four primary categories: R&D and clinical trials, claims data, medical devices data, and other relevant datasets, underscoring the transformative role of AI in healthcare processes. The paper includes sections on investment trends in pharma and biomed, data availability and its applications, the evolution of the pharma industry through AI, real-world case studies demonstrating successful data utilization, and compliance considerations for investors. This summary offers a glimpse into the comprehensive insights provided in the full report by Eagle Alpha, which further includes additional case studies and details on alternative data providers not covered here. For more detailed information and access to a broad catalog of data products, the report encourages contacting Eagle Alpha directly.
Nowcasting as a Driver for Alternative Data Adoption
Nowcasting, as discussed in our alternative data blog, uses real-time data to estimate current conditions, aiding swift decision-making and contrasting with delayed economic indicators.
A Review of Alternative Data Legal and Compliance Key Themes in 2023
In this episode, Peter Greene and Ben Kozinn of Schulte Roth & Zabel review the most prominent legal themes from 2023 and provide some thoughts on what to expect in 2024. In 2023, we saw the regulatory demand placed on consumers of alternative data increase as rapidly as the technology itself, as the SEC continued its scrutiny on the risk of alternative data containing material non-public information and stressed the need for firms to adopt and consistently apply robust due diligence policies and procedures.
Get a Demo
Request a demo of the vendor or buyer journey on our platform to learn how our services and solutions can help you unlock the potential of alternative data.